Taysha Gene Therapies Inc (TSHA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 320,216 | 139,485 | 144,389 | 87,880 | 149,103 |
| Other current assets | 0 | 0 | 2,000 | 0 | 0 |
| TOTAL | $324,647 | $142,130 | $149,868 | $96,417 | $159,602 |
| Non-Current Assets | |||||
| PPE Net | 6,736 | 7,485 | 10,826 | 14,963 | 50,610 |
| Other Non-Current Assets | 11,937 | 10,749 | 12,037 | 14,896 | 3,744 |
| TOTAL | $18,673 | $18,234 | $22,863 | $29,859 | $54,354 |
| Total Assets | $343,320 | $160,364 | $172,731 | $126,276 | $213,956 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,275 | 3,592 | 6,366 | 10,946 | 21,763 |
| Accrued Expenses | 20,277 | 12,862 | 12,284 | 18,287 | 29,983 |
| TOTAL | $26,552 | $26,227 | $36,756 | $62,790 | $51,746 |
| Non-Current Liabilities | |||||
| Long Term Debt | 50,106 | 43,942 | 40,508 | 37,967 | 37,192 |
| Deferred Revenues | N/A | 9,773 | 18,106 | 33,557 | N/A |
| Other Non-Current Liabilities | 19,724 | 18,670 | 20,530 | 24,570 | 29,635 |
| TOTAL | $69,830 | $62,612 | $61,038 | $62,537 | $66,827 |
| Total Liabilities | $96,382 | $88,839 | $97,794 | $125,327 | $118,573 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 287,270 | 205,002 | 187,018 | 63,473 | 38,474 |
| Common Shares | 3 | 2 | 2 | 1 | N/A |
| Retained earnings | -711,300 | -602,305 | -513,007 | -401,441 | -235,649 |
| Other shareholders' equity | -192 | -4,031 | 0 | 0 | 0 |
| TOTAL | $246,938 | $71,525 | $74,937 | $949 | $95,383 |
| Total Liabilities And Equity | $343,320 | $160,364 | $172,731 | $126,276 | $213,956 |